"Do Good. Do Well. Repeat." This is more than a motto - it's the philosophy behind our business, deeply rooted in the concept of shared value. What does it mean? 1. We 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗲 to tackle societal challenges and invest in solutions that create lasting positive change. 2. Through this, we 𝗮𝗰𝗵𝗶𝗲𝘃𝗲 𝘀𝘂𝗰𝗰𝗲𝘀𝘀 responsibly and with integrity, ensuring our prosperity benefits all. 3. We 𝗿𝗲𝗶𝗻𝘃𝗲𝘀𝘁 the value we create into our business and community, driving growth and improvement. By doing so, we create a cycle of positive change, proving that ethical practices and financial performance go hand in hand. Discover more in our 2023 Sustainability Report: https://lnkd.in/d6k62RwC #AtChiesiWeAct #ChiesiGroup #DoGoodDoWellRepeat
Chiesi Group
Fabbricazione di prodotti farmaceutici
Parma, Emilia-Romagna 212.349 follower
Chi siamo
Chiesi is an international, research-focused biopharmaceuticals group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s quality of life and act responsibly towards both the community and the environment. By changing its legal status to a Benefit Corporation in Italy, the US, and France, Chiesi’s commitment to create shared value for society as a whole is legally binding and central to company-wide decision-making. As a certified B Corp since 2019, we’re part of a global community of businesses that meet high standards of social and environmental impact. The company aims to reach Net-Zero greenhouse gases (GHG) emissions by 2035. With over 85 years of experience, Chiesi is headquartered in Parma (Italy), operates in 31 countries, and counts more than 6,500 employees. The Group’s research and development centre in Parma works alongside 6 other important R&D hubs in France, the US, Canada, China, the UK, and Sweden. For further information please visit www.chiesi.com
- Sito Web
-
http://www.chiesi.com
Link esterno per Chiesi Group
- Settore
- Fabbricazione di prodotti farmaceutici
- Dimensioni dell’azienda
- 5001 - 10.000 dipendenti
- Sede principale
- Parma, Emilia-Romagna
- Tipo
- Società privata non quotata
- Settori di competenza
- Pharmaceuticals, Respiratory, Neonatology, Special care e Rare Diseases
Località
-
Principale
Via Paradigna, 131
Parma, Emilia-Romagna 43122, IT
-
Via Palermo 26/A
Parma, 43122, IT
Dipendenti presso Chiesi Group
Aggiornamenti
-
This week leaders from across Chiesi will be attending the European Respiratory Society Congress in Vienna from 7 – 11 September. At the Congress, we will be sharing developments around our steadfast commitment to developing innovative treatments that benefit patients while significantly reducing their impact on the environment If you are attending in person, you can follow our work throughout the Congress: listen in on our sponsored symposia on the 8 and 9 September, then explore one of the 24 accepted abstracts from Chiesi and our affiliates from the 8 -11 of September. Discover more about the insights and innovations we will be presenting at the Congress: https://lnkd.in/dAfZF3ug #ERSCongress2024 #ChiesiGroup
-
Supporting research progress in #Fabrydisease, #Alphamannosidosis and #Cystinosis is our way to make a rare difference. Are you a researcher in the #LysosomalStorageDisorders field? This is your chance to have an impact. Apply now for #FindForRare, the new independently assessed, expert-led initiative, organized and founded by Chiesi Global Rare Diseases Discover the eligibility criteria on https://lnkd.in/dqG4U2ZG #RareDisease #ChiesiGlobalRareDiseases
-
We are adopting a concrete, measurable approach to have a positive impact for our patients, planet, people and communities. Our renewed strategy sets ambitious long-term goals, while remaining flexible to evolving environmental, societal and geopolitical challenges. Take a closer look at our #SustainabilityReport 2023 to learn more: https://lnkd.in/d6k62RwC #AtChiesiWeAct #ChiesiGroup #DoGoodDoWellRepeat
-
+ 1
-
How do we turn our commitment into action? Read our #SustainabilityReport2023 to discover how we are making a positive impact for our patients, planet, and people! This year marks a significant step in our journey. By fully integrating Shared Value & Sustainability into our long-term business strategy, we leverage our collective expertise to drive innovation and foster meaningful societal and environmental change. Discover more: https://lnkd.in/d6k62RwC #AtChiesiWeAct #ChiesiGroup #SharedValue #PurposeFirst
-
+ 1
-
Do you know what the word "rarity" means? It refers to something rare, often something of particular value. However, being rare can also lead to isolation and stigma for those with #RareDiseases. But consider this: each of us is unique in our own way, making us all rare in the end! Discover more about the nuances of rarity at itsrareforme.com #ChiesiGlobalRareDiseases #ItsRareForMe
-
#RareDiseases Spotlight: News from the world 🌎 We're thrilled to announce the expansion of our operations with a new affiliate in #Japan, marking a significant leap forward in our international growth strategy. Recently, we have successfully acquired assets that were already distributed in Japan through our trusted local partners. Leveraging these established products has paved the way for us to take this strategic move. With a direct presence in Japan, we will be able to provide our existing #rarediseases portfolio and innovative pipeline serving the Japanese community. Join us as we embark on this new chapter and continue our commitment to improving healthcare outcomes worldwide. #AtChiesiWeAct Chiesi Global Rare Diseases
-
We remain steadfast in our commitment to the planet. Chiesi is on a journey to achieve Net-Zero greenhouse gas (GHG) emissions by 2035, reflecting our dedication to a sustainable future. In 2023, our efforts were recognized with an A- Rating from the Carbon Disclosure Project (CDP) for our proactive climate actions. We also earned a Platinum medal from Ecovadis for our sustainable practices, covering areas such as the environment, ethics, labor rights, and sustainable procurement. As we look to 2024, we are planning to establish new Net-Zero GHG emissions reduction targets to align with the Science Based Target initiative (SBTi) Corporate Net-Zero standard, further cementing our commitment to high sustainability and ethical standards. Learn more about our ongoing commitment to sustainability: https://lnkd.in/dZcXShMy #ChiesiGroup #ChiesiThePlaceToBe #ClimateAction
-
Our first Chiesi Week – the annual event dedicated to country managers and executives -, has filled us with gratitude and inspiration! Over 450 participants and 15+ speakers from around the globe converged in Parma to shape the future of our company. During this transformative event, we immersed ourselves in external insights, patients’ perspectives, and internal success stories. Together, we reaffirmed our purpose and defined our path for the days ahead. Explore some of the unforgettable highlights from this remarkable week. 🚀 #ChiesiThePlaceToBe #AtChiesiWeACT
-
Creating a positive and inclusive workplace is central to Chiesi's mission. Creating value for people is reflected in our dedication to fair pay, fostering a diverse workforce, and promoting work-life balance for everyone at Chiesi. We believe that investing in our employees' well-being drives our shared success. Discover more here: https://lnkd.in/dZcXShMy #ChiesiGroup #ChiesiThePlaceToBe